Conformis Stock Forecast, Price & News

Conformis (NASDAQ:CFMS) Frequently Asked Questions

Is Conformis a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Conformis in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Conformis stock.
View analyst ratings for Conformis or view top-rated stocks.

How has Conformis' stock price been impacted by Coronavirus?

Conformis' stock was trading at $0.66 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CFMS stock has decreased by 6.2% and is now trading at $0.6190.
View which stocks have been most impacted by COVID-19.

When is Conformis' next earnings date?

Conformis is scheduled to release its next quarterly earnings announcement on Wednesday, March 2nd 2022.
View our earnings forecast for Conformis.

How were Conformis' earnings last quarter?

Conformis, Inc. (NASDAQ:CFMS) announced its quarterly earnings results on Wednesday, November, 3rd. The medical instruments supplier reported ($0.07) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.07). The medical instruments supplier earned $14.25 million during the quarter, compared to the consensus estimate of $14.08 million. Conformis had a net margin of 6.86% and a trailing twelve-month return on equity of 8.19%. During the same period last year, the business earned ($0.09) earnings per share.
View Conformis' earnings history.

What price target have analysts set for CFMS?

1 brokers have issued 12-month price objectives for Conformis' stock. Their forecasts range from $2.00 to $2.00. On average, they expect Conformis' stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 223.1% from the stock's current price.
View analysts' price targets for Conformis or view top-rated stocks among Wall Street analysts.

Who are Conformis' key executives?

Conformis' management team includes the following people:

• Mark A. Augusti, President, Chief Executive Officer & Director
• Gary Maingot, Senior Vice President-Operations
• Robert Howe, CFO, Treasurer & Principal Accounting Officer (LinkedIn Profile)
• Marc Quartulli, Vice President-Clinical Affairs & Market Access
• John Slamin, Senior Vice President-Product Engineering

What is Mark Augusti's approval rating as Conformis' CEO?

15 employees have rated Conformis CEO Mark Augusti on Glassdoor.com. Mark Augusti has an approval rating of 55% among Conformis' employees. This puts Mark Augusti in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Conformis' key competitors?

Some companies that are related to Conformis include Eargo (EAR), Sanara MedTech (SMTI), Sientra (SIEN), Lakeland Industries (LAKE), United Health Products (UEEC), Milestone Scientific (MLSS), Surgalign (SRGA), Invacare (IVC), ReWalk Robotics (RWLK), Alpha Pro Tech (APT), CollPlant Biotechnologies (CLGN), Predictive Oncology (POAI), Myomo (MYO), Nutriband (NTRB) and Bone Biologics (BBLG).
View all of CFMS's competitors.

What other stocks do shareholders of Conformis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Conformis investors own include Advanced Micro Devices (AMD), Martin Midstream Partners (MMLP), Micron Technology (MU), NVIDIA (NVDA), Trevena (TRVN), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), Alibaba Group (BABA) and AT&T (T).

When did Conformis IPO?

(CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Conformis' stock symbol?

Conformis trades on the NASDAQ under the ticker symbol "CFMS."

How do I buy shares of Conformis?

Shares of CFMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Conformis' stock price today?

One share of CFMS stock can currently be purchased for approximately $0.62.

How much money does Conformis make?

Conformis has a market capitalization of $115.19 million and generates $68.76 million in revenue each year. The medical instruments supplier earns $-24.29 million in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Conformis have?

Conformis employs 259 workers across the globe.

What is Conformis' official website?

The official website for Conformis is www.conformis.com.

Where are Conformis' headquarters?

Conformis is headquartered at 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821.

How can I contact Conformis?

Conformis' mailing address is 600 TECHNOLOGY PARK DRIVE, BILLERICA MA, 01821. The medical instruments supplier can be reached via phone at (781) 345-9001, via email at [email protected], or via fax at 781-345-0147.